Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

EHR Embedded Comparative Effectiveness Studies--CPS (EHR-CPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04520009
Recruitment Status : Completed
First Posted : August 20, 2020
Last Update Posted : November 16, 2021
Sponsor:
Collaborators:
Trustees of Dartmouth College
Patient-Centered Outcomes Research Institute
Information provided by (Responsible Party):
Tor D. Tosteson, Dartmouth-Hitchcock Medical Center

Brief Summary:
Randomize Everyone is a research project to develop new informatics systems and statistical methods for supporting randomization processes in EHR systems to do comparative effectiveness research. Two demonstration projects are being conducted in the Dartmouth Hitchcock Medical Center, designed to evaluate different weight loss interventions and common practices in the treatment of chronic low back pain.

Condition or disease Intervention/treatment
Degenerative Spondylolisthesis Behavioral: Activity Restriction Behavioral: Activity as Tolerated

Detailed Description:
EHR Embedded Comparative Effectiveness Studies-CPS will be held in the Center for Pain and Spine at Dartmouth-Hitchcock Medical Center. This study consists of randomizing enrollees to either activity restriction or no activity restriction following lumbar discectomy.

Layout table for study information
Study Type : Observational
Actual Enrollment : 60 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Randomize Everyone: Creating Valid Instrumental Variables for Learning Health Care Systems
Actual Study Start Date : August 3, 2020
Actual Primary Completion Date : October 31, 2021
Actual Study Completion Date : October 31, 2021

Group/Cohort Intervention/treatment
Activity Restriction
Discharge orders for activity restriction
Behavioral: Activity Restriction
Standard post-operative activity instructions (i.e., no bending, twisting, or lifting more than 10 lbs for 4 weeks, no return to work until cleared to do so).

Activity As Tolerated
Discharge orders written for activity as tolerated
Behavioral: Activity as Tolerated
Instructions advising activity as tolerated and return to work based on patient discretion




Primary Outcome Measures :
  1. Factors for patient participation in EHR imbedded study [ Time Frame: Baseline ]
    Patient Survey

  2. Receipt of treatment [ Time Frame: 6 months post-enrollment ]
    Patient Survey

  3. Satisfaction with Treatment [ Time Frame: 6 months post-enrollment ]
    Patient Survey



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients eligible for discectomy
Criteria

Inclusion Criteria:

  • Adults (>18) able to consent
  • Sufficient fluency in English
  • Indications for discectomy
  • Able to restrict activities or to resume activities as tolerated

Exclusion Criteria:

  • Pregnant women
  • Prisoners
  • Children (<18).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04520009


Locations
Layout table for location information
United States, New Hampshire
Dartmouth-HItchcock
Lebanon, New Hampshire, United States, 03756
Sponsors and Collaborators
Dartmouth-Hitchcock Medical Center
Trustees of Dartmouth College
Patient-Centered Outcomes Research Institute
Investigators
Layout table for investigator information
Principal Investigator: Tor Tosteson Dartmouth
Layout table for additonal information
Responsible Party: Tor D. Tosteson, Professor, Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier: NCT04520009    
Other Study ID Numbers: SFD20160
First Posted: August 20, 2020    Key Record Dates
Last Update Posted: November 16, 2021
Last Verified: November 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Spondylolisthesis
Spondylolysis
Spondylosis
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases